18.79  -0.29 (-1.52%)		07-26 16:00
Open: 18.98 High: 19.43 Volume: 1,701		Pre. Close: 19.08 Low: 18.72 Market Cap: 64(M)

Short term
Mid term
Targets	6-month :	23.71	1-year :	27.69
Resists	First :	20.29	Second :	23.71
Pivot price	18.73
Supports	First :	18.16	Second :	16.84
MAs	MA(5) :	19.1	MA(20) :	18.57
	MA(100) :	18.53	MA(250) :	17.92
MACD	MACD :	0.1	Signal :	0
%K %D	K(14,3) :	60.9	D(3) :	66.1
RSI	RSI(14): 49.3
52-week	High :	22.98	Low :	14.51

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ PDEX ] has closed below upper band by 48.1%. Bollinger Bands are 81.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 10 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	19.45 - 19.61	19.61 - 19.72
Low:	18.4 - 18.57	18.57 - 18.68
Close:	18.57 - 18.83	18.83 - 19.01

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

Tue, 23 Jul 2024
LFVN: 3 Under-the-Radar Micro-Cap Stocks to Buy - StockNews.com

Mon, 22 Jul 2024
Spectral AI (NASDAQ:MDAI) & Pro-Dex (NASDAQ:PDEX) Critical Analysis - Defense World

Mon, 15 Jul 2024
Pro-Dex, Inc. (NASDAQ:PDEX) Shares Sold by LSV Asset Management - Defense World

Wed, 26 Jun 2024
Pro Dex director Angelita Rebamontan sells $47k in stock - Investing.com

Thu, 26 Oct 2023
Pro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day Podcast - Yahoo Finance

Mon, 05 Jun 2023
Pro-Dex, Inc. Discusses Record 3rd Quarter Results with The Stock Day Podcast - Newsfile

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	3 (M)
Shares Float	2 (M)
Held by Insiders	34.2 (%)
Held by Institutions	26.6 (%)
Shares Short	5 (K)
Shares Short P.Month	7 (K)

EPS	0.56
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	8.96
Profit Margin	4.1 %
Operating Margin	15.4 %
Return on Assets (ttm)	8.2 %
Return on Equity (ttm)	7.1 %
Qtrly Rev. Growth	9.3 %
Gross Profit (p.s.)	0
Sales Per Share	14.46
EBITDA (p.s.)	2.2
Qtrly Earnings Growth	-57.8 %
Operating Cash Flow	6 (M)
Levered Free Cash Flow	4 (M)

PE Ratio	32.96
PEG Ratio	0
Price to Book value	2.09
Price to Sales	1.29
Price to Cash Flow	11.06

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.